about
Soluble ST2 Testing: A Promising Biomarker in the Management of Heart FailureDiagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure.Non-professional marathon running: RAGE axis and ST2 family changes in relation to open-window effect, inflammation and renal functionThe emerging role of sST2 blocking in the therapy of graft-versus-host disease.Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP.The current status of heart failure diagnostic biomarkers.Do we need another heart failure biomarker: focus on soluble suppression of tumorigenicity 2 (sST2).Soluble ST2 predicts 1-year outcome in patients undergoing transcatheter aortic valve implantation.Prognostic role of soluble suppression of tumorigenicity-2 on cardiovascular mortality in outpatients with heart failure.The Interleukin-33/ST2 Pathway Is Expressed in the Failing Human Heart and Associated with Pro-fibrotic Remodeling of the Myocardium.Diagnosis of chronic heart failure by the soluble suppression of tumorigenicity 2 and N-terminal pro-brain natriuretic peptide.Soluble ST2 in end-stage heart failure, before and after support with a left ventricular assist device.Acute effects of moderate altitude on biomarkers of cardiovascular inflammation and endothelial function and their differential modulation by dual endothelin receptor blockade.sST2 as a New Biomarker of Chronic Kidney Disease-Induced Cardiac Remodeling: Impact on Risk Prediction
P2860
Q28066438-6A06CDC3-C23F-4F40-B01D-31D44543D128Q30386714-B1A3CD79-F2CF-44EA-82D3-287B0469A53FQ37274188-00271D9A-624A-49D3-BDBE-1063D88C76C3Q37407814-A6062D17-46B6-40C7-BB55-9FB8181AAE99Q38400116-714CC6AD-7585-4042-AB2F-DF601FC22E30Q38703882-4ED8DAD3-CFA5-4274-9835-67D7F0798C36Q39059489-94A0C137-E654-499F-A6E9-ADEAD6BD665AQ40401869-A936E524-E099-41B7-8050-50B21B952960Q47101543-CE78A872-E5AA-490B-A506-B61A9FA28552Q47213184-38FA30DE-D2AA-4C53-B512-3358604D73B0Q47911540-2F332302-F706-4F61-8457-1BDF8B24F30FQ48258807-75C14F66-8873-49C7-BCC4-B85CB888651BQ52768529-D324CA6E-98A2-49E4-810A-1FBE82CF7601Q58580704-BCD1E87B-FC1C-455E-ABE5-A2CB27048694
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
ST2 and patient prognosis in chronic heart failure.
@ast
ST2 and patient prognosis in chronic heart failure.
@en
type
label
ST2 and patient prognosis in chronic heart failure.
@ast
ST2 and patient prognosis in chronic heart failure.
@en
prefLabel
ST2 and patient prognosis in chronic heart failure.
@ast
ST2 and patient prognosis in chronic heart failure.
@en
P1476
ST2 and patient prognosis in chronic heart failure.
@en
P2093
Yuhui Zhang
P304
P356
10.1016/J.AMJCARD.2015.01.043
P407
P433
P577
2015-01-24T00:00:00Z